drugset

drugset / Trial / NCT05080569

Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment

NCT05080569 ↗

Phase 4 Recruiting 1008 enrolled UMC Utrecht

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The LUMO study is a multicenter, randomized controlled trial that evaluates the effectivity of luteal phase support in MOH/IUI treatment.

Timeline

Start: 2023-03-01
Primary completion: 2025-12
Completion: 2027-07

Publications

Preesman E, Drechsel K, Crommelin H, Broekmans F, Verpoest W, Broer S; LUMO Study Group. Does luteal phase support in MOH-IUI treatment improve cumulative live birth rates in couples with unexplained subfertility? Study protocol of the LUMO study: a centre, randomised, double-blind, controlled trial with cost-effectiveness analysis. BMJ Open. 2025 Nov 19;15(11):e111872. doi: 10.1136/bmjopen-2025-111872.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Progesterone	Other / unclassified	200 mg	Other

Indications